Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05085405 · ClinicalTrials.gov registry record · NA
Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT05085405 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 80 participants.
The verdict
NCT05085405, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This is a pragmatic, single center, feasibility pilot cluster randomized trial with embedded individual randomization to evaluate implementation strategies to increase the use of evidence-based practices to reduce upper gastrointestinal bleeding risk in patients using combination antithrombotic therapy (including warfarin) and that are managed by the Michigan Medicine anticoagulation monitoring service.
Interventions
- BEHAVIORAL Clinician notification
- BEHAVIORAL Clinician Notification with Nurse Facilitation
- BEHAVIORAL Clinician Notification / Patient Activation
- BEHAVIORAL Clinician Notification with Nurse Facilitation / Patient Activation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-10-11 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05085405
The ClinicalTrials.gov registry entry for NCT05085405 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Clinician notification is the first listed.
NCT05085405 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05085405 about?
NCT05085405 is a clinical study titled "Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial". This is a pragmatic, single center, feasibility pilot cluster randomized trial with embedded individual randomization to evaluate implementation strategies to increase the use of evidence-based practices to reduce upper gastrointestinal bleeding risk in patients using combination antithrombotic ther...
What is the current status of trial NCT05085405?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2021-10-11. Estimated completion is 2022-01-31.
What interventions are being tested in trial NCT05085405?
The interventions under investigation include: Clinician notification (BEHAVIORAL), Clinician Notification with Nurse Facilitation (BEHAVIORAL), Clinician Notification / Patient Activation (BEHAVIORAL), Clinician Notification with Nurse Facilitation / Patient Activation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05085405?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.